More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$804181470
EPS
-1.43
P/E ratio
--
Price to sales
2.24
Dividend yield
--
Beta
0.989249
Previous close
$23.82
Today's open
$24.94
Day's range
$24.79 - $31.51
52 week range
$14.42 - $31.51
show more
CEO
David R. Bailey
Employees
562
Headquarters
Warsaw, IN
Exchange
NASDAQ Global Market
Shares outstanding
26109788
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
OrthoPediatrics Corp. (KIDS) Q3 2026 Earnings Call Transcript
OrthoPediatrics Corp. ( KIDS ) Q3 2026 Earnings Call October 27, 2026 4:30 PM EDT Company Participants David Bailey - President, CEO & Director Fred Hite - CFO, Principal Financial & Accounting Officer, COO and Director Conference Call Participants Philip Taylor - Gilmartin Group LLC Caitlin Roberts - Canaccord Genuity Corp., Research Division Frederick Wise - Stifel, Nicolaus & Company, Incorporated, Research Division Michael Matson - Needham & Company, LLC, Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Ravi Misra - Truist Securities, Inc., Research Division Presentation Operator Good afternoon, and welcome to OrthoPediatrics Corporation's Third Quarter 2026 Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
Seeking Alpha • Oct 28, 2026

OrthoPediatrics: 3 Key Takeaways for Long-Term Investors
OrthoPediatrics raised 2026 revenue guidance to $270 million to $273 million. Third-quarter revenue grew 19% year over year to $72.7 million.
The Motley Fool • Oct 28, 2026

OrthoPediatrics Q3 Earnings Call Highlights
OrthoPediatrics NASDAQ: KIDS reported record third-quarter revenue and raised its full-year sales outlook, citing broad-based demand across its trauma, deformity, scoliosis and specialty bracing businesses, as well as continued progress from recently introduced products.
MarketBeat • Oct 28, 2026

OrthoPediatrics Corp. Reports Third Quarter 2026 Financial Results and Increases 2026 Financial Guidance
Record Third Quarter 2026 Revenue of $72.7 Million , Up 19% Year-over-Year
GlobeNewsWire • Oct 27, 2026

OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.24 per share a year ago.
Zacks Investment Research • Oct 27, 2026

OrthoPediatrics Announces FDA 510(k) Clearance of PNP | Femur Retrograde Nail System and Completes First Implantations
New addition to the Pediatric Nailing Platform expands options for pediatric femoral trauma and deformity correction New addition to the Pediatric Nailing Platform expands options for pediatric femoral trauma and deformity correction
GlobeNewsWire • Oct 27, 2026

OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 27, 2026
WARSAW, Ind., Oct. 13, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2026 financial results on Tuesday, October 27, 2026 after the market closes. OrthoPediatrics will host a conference call on Tuesday, October 27, 2026 at 4:30 p.m. ET to discuss the results.
GlobeNewsWire • Oct 13, 2026

OrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB® Knee 'TractorFIX
WARSAW, Ind., Oct. 07, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) portfolio with a new product launch, the OPSB® Knee 'TractorFIX contracture management orthosis.
GlobeNewsWire • Oct 7, 2026

OrthoPediatrics Sponsors the 10th Pediatric Orthopedic Surgical Techniques Course
Milestone program with record attendance brought together 39 participants from 23 institutions across 22 cities and three countries Milestone program with record attendance brought together 39 participants from 23 institutions across 22 cities and three countries
GlobeNewsWire • Oct 1, 2026

OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations
WARSAW, Ind., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the recent implantation of the 1,000th Tibia Nail using its latest Pediatric Nailing Platform (PNP).
GlobeNewsWire • Sep 22, 2026

¹ Disclosures

Open an M1 investment account to buy and sell OrthoPediatrics Corp. commission-free¹. Build wealth for the long term using automated trading and transfers.